U.S. Code · Título 21
Development, submission, implementation, and assessment of National Drug Control Strategy
21 U.S.C. § 1705
Office of the Law Revision Counsel · release 119-142
Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.
In general
Statement of drug policy priorities
The Director shall release a statement of drug control policy priorities in the calendar year of a Presidential inauguration following the inauguration, but not later than April 1.
National Drug Control Strategy submitted by the President
Not later than the first Monday in February following the year in which the term of the President commences, and every 2 years thereafter, the President shall submit to Congress a National Drug Control Strategy.
Development of the National Drug Control Strategy
Promulgation
The Director shall promulgate the National Drug Control Strategy, which shall set forth a comprehensive plan to reduce illicit drug use and the consequences of such illicit drug use in the United States by limiting the availability of and reducing the demand for illegal drugs and promoting prevention, early intervention, treatment, and recovery support for individuals with substance use disorders.
State and local commitment
The Director shall seek the support and commitment of State, local, and Tribal officials in the formulation and implementation of the National Drug Control Strategy.
Strategy based on evidence
The Director shall ensure the National Drug Control Strategy is based on the best available evidence regarding the policies that are most effective in reducing the demand for and supply of illegal drugs.
Process for development and submission of National Drug Control Strategy
In developing and effectively implementing the National Drug Control Strategy, the Director—
shall consult with—
Contents of the National Drug Control Strategy
In general
The National Drug Control Strategy submitted under subsection (a)(2) shall include the following:
A description of how each goal established under subparagraph (B) will be achieved, including for each goal—
For each year covered by the Strategy, a performance evaluation plan for each goal established under subparagraph (B) for each National Drug Control Program agency, including—
A description of how each goal established under subparagraph (B) was determined, including—
A systematic plan for increasing data collection to enable real time surveillance of drug control threats, developing analysis and monitoring capabilities, and identifying and addressing policy questions related to the National Drug Control Strategy and Program, which shall include—
A plan to expand treatment of substance use disorders, which shall—
Consultation
In developing the plan required under paragraph (1)(M), the Director shall consult with the following:
Additional strategies
In general
The Director shall include in the National Drug Control Strategy the additional strategies described under this paragraph and shall comply with the following:
Requirement for Southwest Border Counternarcotics Strategy
Purposes
The Southwest Border Counternarcotics Strategy shall—
Specific content related to drug tunnels between the United States and Mexico
The Southwest Border Counternarcotics Strategy shall include—
Requirement for Northern Border Counternarcotics Strategy
Purposes
The Northern Border Counternarcotics Strategy shall—
Specific content related to cross-border Indian reservations
The Northern Border Counternarcotics Strategy shall include—
Classified information
Any contents of the National Drug Control Strategy that involve information properly classified under criteria established by an Executive order shall be presented to Congress separately from the rest of the National Drug Control Strategy.
Selection of data and information
In selecting data and information for inclusion in the Strategy, the Director shall ensure—
Submission of revised Strategy
The President may submit to Congress a revised National Drug Control Strategy that meets the requirements of this section—
Failure of Director to Submit National Drug Control Strategy
If the Director does not submit a National Drug Control Strategy to Congress in accordance with subsection (a)(2), not later than five days after the first Monday in February following the year in which the term of the President commences, the Director shall send a notification to the appropriate congressional committees—
Drug Control Data Dashboard
In general
The Director shall collect and disseminate, as appropriate, such information as the Director determines is appropriate, but not less than the information described in this subsection. The data shall be publicly available in a machine-readable format on the online portal of the Office, and to the extent practicable on the Drug Control Data Dashboard.
Establishment
The Director shall publish to the online portal of the Office in a machine-readable, sortable, and searchable format, or to the extent practicable, establish and maintain a data dashboard on the online portal of the Office to be known as the “Drug Control Data Dashboard”. To the extent practicable, when establishing the Drug Control Dashboard, the Director shall ensure the user interface of the dashboard is constructed with modern design standards. To the extent practicable, the data made available on the dashboard shall be publicly available in a machine-readable format and searchable by year, agency, drug, and location.
Data
The data included in the Drug Control Data Dashboard shall be updated quarterly to the extent practicable, but not less frequently than annually and shall include, at a minimum, the following:
For each substance identified by the Director as having a significant impact on the prevalence of illicit drug use—
data sufficient to show the quantities of such substance available in the United States, including—
data sufficient to show the frequency of use of such substance, including—
For the calendar year and each of the previous three years data sufficient to show, disaggregated by State and, to the extent feasible, by region within a State, county, or city, the following:
Development of an annual national drug control assessment
Timing
Not later than the first Monday in February of each year, the Director shall submit to the President, Congress, and the appropriate congressional committees, a report assessing the progress of each National Drug Control Program agency toward achieving each goal, objective, and target contained in the National Drug Control Strategy applicable to the prior fiscal year.
Process for development of the annual assessment
Not later than November 1 of each year, the head of each National Drug Control Program agency shall submit, in accordance with guidance issued by the Director, to the Director an evaluation of progress by the agency with respect to the National Drug Control Strategy goals using the performance measures for the agency developed under this chapter, including progress with respect to—
Contents of the annual assessment
The Director shall include in the annual assessment required under paragraph (1)—
Performance measurement system
Not later than February 1 of each year, the Director shall submit to Congress as part of the National Drug Control Strategy, a description of a national drug control performance measurement system, that—
coordinates the development and implementation of national drug control data collection and reporting systems to support policy formulation and performance measurement, including an assessment of—
Modifications
A description of any modifications made during the preceding year to the national drug performance measurement system described in subsection (c) 4 shall be included in each report submitted under subsection (b).5
(Pub. L. 105–277, div. C, title VII, §§ 706, 715, Oct. 21, 1998, 112 Stat. 2681–681, 2681–693; Pub. L. 109–469, title II, §§ 201, 202, title VI, § 602, Dec. 29, 2006, 120 Stat. 3513, 3517, 3533; Pub. L. 115–271, title VIII, §§ 8202(a), (b)(2), 8221(a), Oct. 24, 2018, 132 Stat. 4110, 4134; Pub. L. 116–74, § 2(a)(1), (2), (c)(1)(B), (d), Nov. 27, 2019, 133 Stat. 1155, 1158; Pub. L. 117–263, div. E, title LIII, § 5302, Dec. 23, 2022, 136 Stat. 3249.)